Clinical trial
Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With…
NCT00083161 · Gundersen Lutheran Health System, Other · Completed
Key facts
| NCT number | NCT00083161 |
|---|---|
| Title | Cisplatin, Etoposide, and Cyclophosphamide in Treating Patients With Extensive-Stage Small Cell Lung Cancer |
| Official title | Pilot Study of a Combination of Standard Etoposide/Cisplatin and Metronomic Cyclophosphamide in Patients With Newly Diagnosed Extensive Stage Small Cell Lung Cancer |
| Lead sponsor | Gundersen Lutheran Health System, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, cyclophosphamide, etoposide |
| Enrollment | 8 |
| Start date | Jun 1, 2003 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | May 17, 2004 |
| Last update posted | Sep 5, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: